Dr. Maxwell Lloyd shared the importance of improving patient access to innovative therapies like Orserdu at the 2024 San Antonio Breast Cancer Symposium.

Research presented at SABCS 2024 provided new insights that may influence the management of early and advanced breast cancer.

IntroductionThe global cancer therapeutics market is on an exponential growth trajectory, driven by advancements in treatment ...

Dawn Klemow, MD, assistant clinical professor, University of Texas Southwestern Medical Center, previews some of the most recent advances in breast cancer treatment.

Hundreds of FDA-approved drugs tested directly on a patient’s tumor sample. Could this be a gamechanger for cancer management ...

The Breast Reconstruction Market has witnessed remarkable advancements in recent years, driven by medical innovations, a ...

The $30 million facility was made possible, in part, through a $4 million contribution through the AdventHealth Palm Coast Foundation and its donors.

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...

Oklahoma Cancer Specialists and Research Institute has announced its new status as a main member of NRG Oncology, enhancing ...

Researchers sought to determine the effect of changes in screening guidelines on incidence of breast cancer by stage at diagnosis and surgical management.

The key to reducing cervical cancer cases lies in regular screenings, education, and open conversations about the importance ...

“We are living in the dark ages,” said Robyn Spoon, a member of the coalition and CEO of Elevate Childhood Cancer Research ...